Range of qualified clients: CDEC mentioned the uncertainty in the volume of patients with reasonably critical to severe hemophilia B in Canada eligible for etranacogene dezaparvovec. Clinical experts consulted by CADTH indicated that some clients who will be categorized as getting mild or moderate sickness might have a intense bleeding https://hemgenix95937.blogs100.com/36313320/the-5-second-trick-for-hemgenix